Search for a Medicine

  • Medicines
 
 

Showing 241-260 of 418 matching medicines

Product listings were last updated on 29/04/2024
Trade Name Licence Number & Holder Documents
Ontilyv
Capsule, hard

Compare
EU/1/21/1578/001-004
Authorised: 21/02/2022
BIAL-Portela & Ca, S.A.
SPC PIL IPAR
Ontilyv
Capsule, hard

Compare
EU/1/21/1578/005-010
Authorised: 21/02/2022
BIAL-Portela & Ca, S.A.
SPC PIL IPAR
Ontozry
Film-coated tablet

Compare
EU/1/21/1530/001
Authorised: 26/03/2021
Angelini Pharma Italia S.P.A.
SPC PIL IPAR
Ontozry
Film-coated tablet

Compare
EU/1/21/1530/002-004
Authorised: 26/03/2021
Angelini Pharma Italia S.P.A.
SPC PIL IPAR
Ontozry
Film-coated tablet

Compare
EU/1/21/1530/005-007
Authorised: 26/03/2021
Angelini Pharma Italia S.P.A.
SPC PIL IPAR
Ontozry
Film-coated tablet

Compare
EU/1/21/1530/008-010
Authorised: 26/03/2021
Angelini Pharma Italia S.P.A.
SPC PIL IPAR
Ontozry
Film-coated tablet

Compare
EU/1/21/1530/011-013
Authorised: 26/03/2021
Angelini Pharma Italia S.P.A.
SPC PIL IPAR
Ontruzant
Powder for concentrate for solution for infusion

Compare
EU/1/17/1241/001
Authorised: 15/11/2017
Samsung Bioepis NL B.V.
SPC PIL IPAR
Onureg
Film-coated tablet

Compare
EU/1/21/1556/001-002
Authorised: 17/06/2021
Celgene Europe B.V.
SPC PIL IPAR
Onureg
Film-coated tablet

Compare
EU/1/21/1556/003-004
Authorised: 17/06/2021
Celgene Europe B.V.
SPC PIL IPAR
Onytec 80mg/g medicated nail lacquer
Medicated nail lacquer

Compare
PA1005/002/001
Authorised: 28/09/2012
Polichem S.A.
SPC PIL
Opatanol
Eye drops, solution

Compare
EU/1/02/217/001
Authorised: 17/05/2002
Novartis Europharm Limited
SPC PIL IPAR
Opatanol
Eye drops, solution

Compare
EU/1/02/217/002
Authorised: 17/05/2002
Novartis Europharm Limited
SPC PIL IPAR
Opdivo
Concentrate for solution for infusion

Compare
EU/1/15/1014/001-002

Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Opdualag
Concentrate for solution for infusion

Compare
EU/1/22/1679/001
Authorised: 15/06/2022
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Opfolda
Capsule, hard

Compare
EU/1/23/1737/001-002
Authorised: 26/06/2023
Amicus Therapeutics Europe Limited
SPC PIL IPAR
Oprymea
Prolonged-release tablet

Compare
EU/1/08/469/026-029

KRKA, d.d., Novo mesto
SPC PIL IPAR
Oprymea
Prolonged-release tablet

Compare
EU/1/08/469/030-033

KRKA, d.d., Novo mesto
SPC PIL IPAR
Oprymea
Prolonged-release tablet

Compare
EU/1/08/469/034-037

KRKA, d.d., Novo mesto
SPC PIL IPAR
OPRYMEA
Prolonged-release tablet

Compare
EU/1/08/469/038-041

Krka d.d., Novo mesto
SPC PIL IPAR